Y. on May 1 up to 3, 2012 (booth 1952).
“Gerresheimer is a strong partner to the pharma industry, delivering innovative packaging products of excellent quality that satisfy all requirements of safety and user friendliness“, said Mike Fischer, Vice President Sales, Tubular Glass Americas.
Demand for syringe systems has increased vastly as a result of the increasingly complex and varied requirements posed by the healthcare market, especially physicians and patients, to the pharma and healthcare industry. The Gerresheimer Group offers a comprehensive and innovative portfolio of pharmaceutical primary packaging products and is one of the leading experts in the development and manufacture of syringes made from glass and plastic (cyclic olefins). The ClearJectTM plastic syringe systems are manufactured by Gerresheimer’s Japanese partner Taisei Kako.
Gerresheimer manufactures glass pre-fillable syringes as bulk or ready-to-fill products. RTF®-brand ready-to-fill glass syringes can have multicolor printing, a laser-applied identity code and a tamper-evident closure system. They are also delivered to the pharma industry sterile, pre-assembled and, if desired, with baked-on siliconization.
Gerresheimer offers chemically tempered glass cartridges for use in conjunction with pen systems and auto-injectors.
Patients who use pen systems or auto-injectors on a daily basis and are familiar with the use of glass cartridges are aware of the breakage risk. Chemically tempered glass cartridges could offer these patients greater safety in future.
Gerresheimer Tubular Glass Products
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of around one billion euros and has over 10,000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.